You have read all your free articles, to continue reading subscribe to read the rest of this content.
Nordic Nanovector has raised MNOK 500 in gross proceeds through a private placement of 4,374,244 new shares. Nordic Nanovector intends to use the net proceeds to fund a Phase 2 combination study of Betalutin® and Rituximab CD20, fund a Phase 1 study and GMP manufacturing for 177Lu-conjugated cAlready a subscriber…
The Swedish biotech company Pila Pharma has announced the decision to list the company. The Initial Public Offering (IPO), aiming for listing of the company’s shares on one of the unregulated stock exchanges in Sweden, is targeted for Q2-2021. To facilitate the IPO process, Göteborg Corporate Already a subscriber Login…
Sigrid Therapeutics has announced the publication of a multifaceted, scientific study in the peer-reviewed journal Advanced Healthcare Materials showing that a new approach using mesoporous silica particles (MSPs) can be used to prevent type 2-diabetes and treat obesity. By blocking food enzyme aAlready a subscriber Login You have read all…
AstraZeneca and MSD have announced that Lynparza (olaparib) has been approved in the US for patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC). The approval by the US Food and Drug Administration (FDA) was based on results fromAlready a subscriber Login You have read all your…
